Susamita Kesh, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 3051 Churchill Dr Ste 130, Flower Mound, TX 75022 Phone: 972-539-0086 Fax: 972-355-9680 |
Marie Holman Fitzgerald, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3051 Churchill Dr Ste 130, Flower Mound, TX 75022 Phone: 972-539-0086 Fax: 972-355-9680 |
Dr. Nana Mireku, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3051 Churchill Dr Ste 130, Flower Mound, TX 75022 Phone: 972-539-0086 Fax: 972-355-9680 |
Dr. Mary Brandt Hudelson, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3051 Churchill Dr, Ste 130, Flower Mound, TX 75022 Phone: 972-539-0086 Fax: 972-355-9680 |
Sherry Barnett, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 3121 Cross Timbers Rd Ste 100, Flower Mound, TX 75028 Phone: 940-503-4447 |
News Archive
Speaking at a workshop on maternal morbidity and mortality in Korofidua, Ghana, on Thursday that was organized for journalists in the region, acting Eastern Regional Director of Health Services Larbi Addo challenged the media to help change negative perceptions about pregnancy and child-bearing in an effort to reduce maternal and infant mortality in the country, GhanaWeb reports.
In this audio report from United Nations Radio, Marleen Temmerman, head of the Department of Reproductive Health and Research at the WHO, talks to the U.N.'s Beng Poblete-Enriquez about preventable deaths among women globally.
The world's pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week.
Despite concerns expressed by the World Bank and the WHO that the current economic climate would lead donor countries to scale back development assistance, a study published online Friday in the WHO Bulletin finds what the authors "described as 'surprisingly little' evidence that economic downturns are associated with deep cuts in aid, at least in the first few years of a financial crisis," Reuters reports.
Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.
› Verified 8 days ago